Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Oral Sodium Blood Pressure in Normal Weight, Overweight and Obese Volunteers (PLADSEL)

The recruitment status of this study is unknown because the information has not been verified recently.
Verified February 2012 by Poitiers University Hospital.
Recruitment status was  Recruiting
Information provided by (Responsible Party):
Poitiers University Hospital Identifier:
First received: February 9, 2012
Last updated: February 13, 2012
Last verified: February 2012

The primary objective of this study is to analyze the sensitivity of blood pressure to oral salt intake. Matched male and female participants will be selected as normal weight, overweight, and obese.

Participating subjects will have a first visit with blood pressure measurement and a blood sample. In two consecutive phases of one week, subjects will receive 12 pills of sodium (6 grams) or corresponding placebo. Blood pressure will be measured at the end of each phase.

Condition Intervention Phase
Other: sodium chloride
Other: Methylcellulose crystalline
Phase 2

Study Type: Interventional
Official Title: Simplification of the Test of Sensibility in the Salt: Preliminary Study at the Child and the Adult

Resource links provided by NLM:

Further study details as provided by Poitiers University Hospital:

Arms Assigned Interventions
Experimental: chlorure de sodium Other: sodium chloride
sodium chloride 500mg
Placebo Comparator: Methylcellulose Other: Methylcellulose crystalline
Methylcellulose 37 ml


Ages Eligible for Study:   6 Years to 45 Years   (Child, Adult)
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • Informed consent
  • Age 18-45 for adults and 6-8 for children

Exclusion Criteria:

  • African ethnicity (known to affect blood pressure sensitivity to salt)
  • Chronic condition affecting blood pressure
  • Diabetes (known to affect blood pressure sensitivity to salt)
  • Hypertension
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT01532401

Contact: Samy HADJADJ, MD 0549443043

Poitiers University Hospital Recruiting
Poitiers, France, 86021
Contact: Samy HADJADJ, MD    0549443043   
Sponsors and Collaborators
Poitiers University Hospital
Principal Investigator: Samy HADJADJ, MD CHU DE POITIERS-Service d'endocrinologie
  More Information

Responsible Party: Poitiers University Hospital Identifier: NCT01532401     History of Changes
Other Study ID Numbers: PLADSEL 2010-023410-31 
Study First Received: February 9, 2012
Last Updated: February 13, 2012
Health Authority: France: Afssaps - Agence française de sécurité sanitaire des produits de santé (Saint-Denis)

Keywords provided by Poitiers University Hospital:
Blood pressure processed this record on September 27, 2016